Avid Bioservices Inc (CDMO)
8.25
+0.05
(+0.61%)
USD |
NASDAQ |
May 03, 16:00
8.23
-0.02
(-0.24%)
After-Hours: 20:00
Avid Bioservices Free Cash Flow (Quarterly): -0.801M for Jan. 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.801M |
| October 31, 2023 | -1.224M |
| July 31, 2023 | -14.39M |
| April 30, 2023 | -22.08M |
| January 31, 2023 | -18.24M |
| October 31, 2022 | -38.24M |
| July 31, 2022 | -11.96M |
| April 30, 2022 | -23.95M |
| January 31, 2022 | -14.83M |
| October 31, 2021 | 2.978M |
| July 31, 2021 | -11.14M |
| April 30, 2021 | 13.71M |
| January 31, 2021 | 2.452M |
| October 31, 2020 | 7.915M |
| July 31, 2020 | -2.762M |
| April 30, 2020 | 2.26M |
| January 31, 2020 | -2.676M |
| October 31, 2019 | 4.937M |
| July 31, 2019 | -2.506M |
| April 30, 2019 | 5.394M |
| January 31, 2019 | -3.884M |
| October 31, 2018 | -6.967M |
| July 31, 2018 | -7.64M |
| April 30, 2018 | 0.46M |
| January 31, 2018 | -8.968M |
| Date | Value |
|---|---|
| October 31, 2017 | -8.664M |
| July 31, 2017 | -12.61M |
| April 30, 2017 | -12.54M |
| January 31, 2017 | -12.41M |
| October 31, 2016 | 0.344M |
| July 31, 2016 | -18.20M |
| April 30, 2016 | -6.586M |
| January 31, 2016 | -10.77M |
| October 31, 2015 | -12.78M |
| July 31, 2015 | -18.33M |
| April 30, 2015 | -6.65M |
| January 31, 2015 | -11.69M |
| October 31, 2014 | -12.73M |
| July 31, 2014 | -13.99M |
| April 30, 2014 | -6.721M |
| January 31, 2014 | -8.625M |
| October 31, 2013 | -5.512M |
| July 31, 2013 | -8.151M |
| April 30, 2013 | -4.883M |
| January 31, 2013 | -6.929M |
| October 31, 2012 | -9.676M |
| July 31, 2012 | -0.291M |
| April 30, 2012 | -9.187M |
| January 31, 2012 | -8.908M |
| October 31, 2011 | -9.703M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-38.24M
Minimum
Oct 2022
13.71M
Maximum
Apr 2021
-6.871M
Average
-2.676M
Median
Jan 2020
Free Cash Flow (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 20.70M |
| Creative Medical Technology Holdings Inc | -1.895M |
| Viking Therapeutics Inc | -6.134M |
| Stereotaxis Inc | -2.439M |
| MAIA Biotechnology Inc | -3.992M |